Table 10.
Comparison of incidence of abnormal laboratory indexes between SFI and placebo groups.
| Laboratory index | SFI (n=78) | Placebo (n=79) |
|---|---|---|
| Blood routine | ||
| White blood cell count | 12 (16.00%) | 9 (11.84%) |
| Red blood cell count | 10 (13.33%) | 9 (11.84%) |
| Hemoglobin | 15 (20.00%) | 12 (15.79%) |
| Blood platelet count | 11 (14.67%) | 8 (10.53%) |
| Urine routine | ||
| Urine protein | 6 (11.11%) | 10 (16.13%) |
| Urine sugar | 4 (7.41%) | 3 (4.84%) |
| Urine erythrocyte | 8 (14.81%) | 10 (16.13%) |
| Urine white blood cell count | 11 (20.37%) | 8 (12.90%) |
| Stool routine | ||
| Red blood cell | 0 (0.00%) | 0 (0.00%) |
| White blood cell | 2 (7.14%) | 0 (0.00%) |
| Occult blood | 6 (21.43%) | 2 (5.13%) |
| Hepatic and renal function | ||
| Alanine transaminase (ALT) | 6 (8.45%) | 6 (8.57%) |
| Glutamic oxalacetic transaminase (AST) | 7 (9.59%) | 5 (6.76%) |
| Total bilirubin | 2 (2.90%) | 5 (7.35%) |
| Urea nitrogen | 17 (22.97%) | 13 (17.33%) |
| Creatinine | 16 (21.33%) | 20 (26.67%) |
| Electrolytes | ||
| K | 5 (6.58%) | 2 (2.60%) |
| Na | 5 (6.58%) | 6 (7.79%) |
| Cl | 3 (3.95%) | 5 (6.49%) |